NVCR Stock Analysis: Buy, Sell, or Hold?
NVCR - NovoCure Limited Ordinary Shares
$15.92
-0.03 (-0.19%)
▼
5d:
-1.73%
30d:
-8.4%
90d:
-7.44%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 29, 2026
27d
Get Alerted When NVCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NVCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NVCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NVCR is currently trading at $15.92, which is considered slightly low relative to its 30-day fair value range of $15.88 to $17.54.
Technical Outlook: Technically, NVCR is in a strong downtrend. Immediate support is located at $15.20, while resistance sits at $16.87.
Market Sentiment: NVCR scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $27.14 (+70.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NVCR is in a strong downtrend. Immediate support is located at $15.20, while resistance sits at $16.87.
Market Sentiment: NVCR scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $27.14 (+70.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$15.88 -
$17.54
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Protect Your Profits
Holding NVCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (82/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 70.2% below Wall St target ($27.14)
- CAUTION: Bottoming setup, but lagging the sector by 23% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$15.88 -
$17.54
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$15.20
Resistance Level
$16.87
Current Trend
Strong Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.54
Wall Street Target
$27.14
(+70.2%)
Revenue Growth (YoY)
15.6%
Earnings Growth (YoY)
-6.0%
Profit Margin
-21.2%
Share & Embed Analysis
Last updated: October 01, 2026 4:36 PM ET
Data refreshes hourly during market hours. Next update: 5:36 PM
Data refreshes hourly during market hours. Next update: 5:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 57 HOLD |
Advanced NVCR Option Strategies
Professional options setups generated by AI based on today's NVCR price and gamma walls.
